UNSPSC 51143703: Amitriptyline/chlordiazepoxide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN900. This VA Drug Class (CN900) classifies this compound as belonging to the group CNS MEDICATIONS, OTHER.

UNSPSC 51143703 Amitriptyline/chlordiazepoxide is a Commodity code nominally covering pharmaceutical combination products, but recent state and local solicitations tagged under this code show minimal relevant activity. Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually — a procurement plainly unrelated to the code's stated pharmaceutical scope. The mismatch suggests either a tagging error in the source data or a misalignment between the code designation and actual purchasing need. No additional recent state and local opportunities appear in the available record for this code.

The single posted opportunity originated from a county public health department (Seminole County Community Health Building, Sanford, Florida) with quarterly delivery requirements and a two-year initial term plus one-year renewal option. The solicitation required electronic bid submission, E-Verify compliance, drug-free workplace certification, and standard commercial insurance coverage. Potential FEMA funding introduced federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act, though no explicit set-aside designations for disadvantaged enterprises were noted. Given the scarcity and mismatch of recent activity, this code warrants close review before investment — the posted opportunity does not align with the code's pharmaceutical product classification, and no additional state and local purchasing activity is evident in current records.